Spierings Julia, Schriemer Rita, Dittmar Sonja, de Pundert Lian, de Vries-Bouwstra Jeska, van den Ende Els, Vonk Madelon
Department of Rheumatology and Clinical Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands.
NVLE, Dutch Patient Organization for Systemic Autoimmune Diseases, Utrecht, The Netherlands.
J Scleroderma Relat Disord. 2021 Feb;6(1):96-101. doi: 10.1177/2397198320953063. Epub 2020 Sep 10.
Systemic sclerosis is a rare and complex disease. Optimal management of patients requires knowledge and experience and, importantly, intensive collaboration between hospitals and multidisciplinary teams. Definition and recognition of expert centres in systemic sclerosis is currently lacking, which complicates collaboration between centres and leaves patients poorly informed. The aim of this study was to develop a set of requirements for two types of systemic sclerosis centres in order to establish a nationwide structure for an optimal and transparent organization of care.
A three-round Delphi study was conducted among a panel of rheumatologists working at university or regional hospitals across the Netherlands. Prior to the final consensus round, a session with a patient panel (N = 22) was held. The results of this meeting were described in the last round for rheumatologists. Criteria were divided into five categories: (1) medical care, (2) case load, (3) collaboration, (4) research, (5) training of staff, and (6) other. In the first round, criteria derived from literature were proposed and participants could add criteria that were missing. For every item, participants could indicate if they thought the item should be included for two types of systemic sclerosis centres: (1) systemic sclerosis expert centre or (2) systemic sclerosis treatment centres. Consensus was reached when more than 85% of the panel agreed.
In total, 47 rheumatologists participated in Delphi round 1, 35 in round 2 and 43 in round 3. Additional suggestions were added by the patient panel (n = 22). Consensus was reached for the requirements of systemic sclerosis expert centres (45 items) and systemic sclerosis treatment centres (29 items) including minimal caseloads of annual suspected systemic sclerosis cases and total patients in care.
Requirements of centres for systemic sclerosis care in the Netherlands were established in this study. Feasibility of certification should be evaluated next. Our proposed list can serve as a model for other countries.
系统性硬化症是一种罕见且复杂的疾病。对患者进行最佳管理需要知识和经验,重要的是,还需要医院与多学科团队之间的密切协作。目前缺乏系统性硬化症专家中心的定义和认定,这使得各中心之间的协作变得复杂,患者也了解不足。本研究的目的是为两种类型的系统性硬化症中心制定一套要求,以便建立一个全国性的结构,实现最佳且透明的医疗组织。
在荷兰各地大学或地区医院工作的一组风湿病学家中进行了三轮德尔菲研究。在最后一轮达成共识之前,与一个患者小组(N = 22)举行了一次会议。在最后一轮中向风湿病学家描述了这次会议的结果。标准分为五类:(1)医疗护理,(2)病例量,(3)协作,(4)研究,(5)员工培训,以及(6)其他。在第一轮中,提出了从文献中得出的标准,参与者可以补充遗漏的标准。对于每个项目,参与者可以表明他们是否认为该项目应纳入两种类型的系统性硬化症中心:(1)系统性硬化症专家中心或(2)系统性硬化症治疗中心。当超过85%的专家小组同意时达成共识。
共有47名风湿病学家参与了第一轮德尔菲研究,35名参与了第二轮,43名参与了第三轮。患者小组(n = 22)增加了其他建议。就系统性硬化症专家中心(45项)和系统性硬化症治疗中心(29项)的要求达成了共识,包括每年疑似系统性硬化症病例和在治患者总数的最低病例量。
本研究确定了荷兰系统性硬化症护理中心的要求。接下来应评估认证的可行性。我们提出的清单可作为其他国家的一个范例。